These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 12149466)

  • 1. Adipose tissue mass can be regulated through the vasculature.
    Rupnick MA; Panigrahy D; Zhang CY; Dallabrida SM; Lowell BB; Langer R; Folkman MJ
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10730-5. PubMed ID: 12149466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice.
    Bergers G; Javaherian K; Lo KM; Folkman J; Hanahan D
    Science; 1999 Apr; 284(5415):808-12. PubMed ID: 10221914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antiangiogenic therapy on slowly growing, poorly vascularized tumors in mice.
    Beecken WD; Fernandez A; Joussen AM; Achilles EG; Flynn E; Lo KM; Gillies SD; Javaherian K; Folkman J; Shing Y
    J Natl Cancer Inst; 2001 Mar; 93(5):382-7. PubMed ID: 11238700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anginex, a designed peptide that inhibits angiogenesis.
    Griffioen AW; van der Schaft DW; Barendsz-Janson AF; Cox A; Struijker Boudier HA; Hillen HF; Mayo KH
    Biochem J; 2001 Mar; 354(Pt 2):233-42. PubMed ID: 11171099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of angiogenesis enter phase III testing.
    Nelson NJ
    J Natl Cancer Inst; 1998 Jul; 90(13):960-3. PubMed ID: 9665141
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiangiogenesis -- therapeutic strategies and clinical implications for brain tumors.
    Puduvalli VK; Sawaya R
    J Neurooncol; 2000; 50(1-2):189-200. PubMed ID: 11245279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice.
    Moulton KS; Heller E; Konerding MA; Flynn E; Palinski W; Folkman J
    Circulation; 1999 Apr; 99(13):1726-32. PubMed ID: 10190883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis research enjoys growth spurt in the 1990s.
    Ziegler J
    J Natl Cancer Inst; 1996 Jun; 88(12):786-8. PubMed ID: 8637041
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice.
    Bråkenhielm E; Cao R; Gao B; Angelin B; Cannon B; Parini P; Cao Y
    Circ Res; 2004 Jun; 94(12):1579-88. PubMed ID: 15155527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General aspects of anti-angiogenesis and cancer therapy.
    Zogakis TG; Libutti SK
    Expert Opin Biol Ther; 2001 Mar; 1(2):253-75. PubMed ID: 11727534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipose tissue growth and regression are regulated by angiopoietin-1.
    Dallabrida SM; Zurakowski D; Shih SC; Smith LE; Folkman J; Moulton KS; Rupnick MA
    Biochem Biophys Res Commun; 2003 Nov; 311(3):563-71. PubMed ID: 14623307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The angiogenic inhibitor TNP-470 decreases caloric intake and weight gain in high-fat fed mice.
    White HM; Acton AJ; Considine RV
    Obesity (Silver Spring); 2012 Oct; 20(10):2003-9. PubMed ID: 22510957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fumagillin reduces adipose tissue formation in murine models of nutritionally induced obesity.
    Lijnen HR; Frederix L; Van Hoef B
    Obesity (Silver Spring); 2010 Dec; 18(12):2241-6. PubMed ID: 20094042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses to anti-angiogenic therapies.
    Paller AS
    J Investig Dermatol Symp Proc; 2000 Dec; 5(1):83-6. PubMed ID: 11147681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy.
    Hahnfeldt P; Panigrahy D; Folkman J; Hlatky L
    Cancer Res; 1999 Oct; 59(19):4770-5. PubMed ID: 10519381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer drug targets: approaching angiogenesis.
    Keshet E; Ben-Sasson SA
    J Clin Invest; 1999 Dec; 104(11):1497-501. PubMed ID: 10587512
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitors of angiogenesis in a clinical perspective.
    Voest EE
    Anticancer Drugs; 1996 Sep; 7(7):723-7. PubMed ID: 8949981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multitarget angiogenesis inhibitor, CTT peptide-endostatin mimic-kringle 5, prevents diet-induced obesity.
    Wang H; Shi Y; Gu J
    J Mol Med (Berl); 2020 Dec; 98(12):1753-1765. PubMed ID: 33141247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of Adipose Tissue Mass by the Angiogenesis Inhibitor ALS-L1023 from Melissa officinalis.
    Park BY; Lee H; Woo S; Yoon M; Kim J; Hong Y; Lee HS; Park EK; Hahm JC; Kim JW; Shin SS; Kim MY; Yoon M
    PLoS One; 2015; 10(11):e0141612. PubMed ID: 26599360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis inhibitors in lung cancer.
    Kim ES; Herbst RS
    Curr Oncol Rep; 2002 Jul; 4(4):325-33. PubMed ID: 12044242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.